Stephen V Liu: Neoadjuvant vs Perioperative Immunotherapy in NSCLC at NYLCF26

Stephen V Liu, Director of Thoracic Oncology, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on X:

“Dr. Solange Peters at NYLCF26 with some provocative points about neoadjuvant vs perioperative immunotherapy in NSCLC. Great interest on de-escalation but caution in systemic empirical efforts.

Need to understand where we can give less and when more is actually needed.”

Other articles featuring Stephen V Liu on OncoDaily.